Tempest Therapeutics, Inc. TPST 深 滬
已收盤 05-08 16:00:00 美东时间
1.99
+0.020
+1.02%
華盛通- 最 高2.05
- 今 開2.00
- 成交量 8.34万股
- 最 低 1.97
- 昨 收 1.97
- 總市值 2854.46万
- 52周最高 12.23
- 市盈率 靜 --
- 換手率 0.58%
- 52周最低 1.50
- 委 比 51.79%
- 總股本 1434.40万
- 歷史最高 3381.30
- 量 比 0.58
- 振 幅 4.06%
- 歷史最低 1.50
- 每 手 1
- 風險率 3.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tempest Therapeutics Reaches Milestone In TPST-2003 Manufacturing Process
TPST-2003 is an autologous CD19/BCMA dual-targeting CAR-T therapy designed to improve response depth and durability in patients with relapsed/refractory multiple myeloma ("rrMM") through a parallel dual-targeting CAR
04-22 20:10
Tempest Therapeutics Q4 EPS $(0.62) Beats $(3.52) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(3.52) by 82.39 percent. This is a 87.77 percent increase over losses of $(5.07) per share
03-30 21:06
美股夜盘 | Tempest Therapeutics, Inc.涨36.78%，最新股价2.38美元
Tempest Therapeutics, Inc.涨36.78%，报2.38美元
03-26 15:06
美股夜盘 | Southland Holdings, Inc.涨49.24%，Tempest Therapeutics, Inc.涨36.21%
Southland Holdings, Inc.涨49.24%；Tempest Therapeutics, Inc.涨36.21%；Rani Therapeutics涨22.81%
03-26 15:01
美股夜盘 | Southland Holdings, Inc.涨53.03%，Navan, Inc. Class A涨26.45%
Southland Holdings, Inc.涨53.03%；Navan, Inc. Class A涨26.45%；Rani Therapeutics涨22.81%
03-26 13:03
美股夜盘 | Southland Holdings, Inc.涨50.76%，Navan, Inc. Class A涨27.32%
Southland Holdings, Inc.涨50.76%；Navan, Inc. Class A涨27.32%；Epsium Enterprise涨22.14%
03-26 09:04
美股夜盘 | Southland Holdings, Inc.涨57.58%，Navan, Inc. Class A涨23.28%
Megan Holdings Limited Class A涨-86.88%；Cibus, Inc. Class A涨-18.82%；Next Technology涨-16.95%
03-26 08:12
Tempest Therapeutics Announces Up To $6M Private Placement; Warrants Will Have Exercise Price Of $2.16/Share
Tempest Therapeutics has entered into definitive agreements for the purchase and sale of an aggregate of 925,927 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 925,927
03-23 20:03
Tempest Therapeutics Selects Cincinnati Children's AGCTC As Lead Contract Development And Manufacturing Partner To Conduct Formal Technology Transfer Of TPST-2003 For Treatment Of rrMM
Cincinnati Children's Applied Gene and Cell Therapy Center selected to conduct tech transfer, development and IND-enabling manufacturingAll activities other than long-term stability testing planned to be complete in Q3
03-11 20:06
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
